Question 1

Does Woodline Partners own KYMR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Woodline Partners holds 500,868 shares of KYMR (Kymera Therapeutics), worth $57.4M.

Question 2

How many shares of KYMR does Woodline Partners own?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners holds 500,868 shares of KYMR (Kymera Therapeutics).

Question 3

What is Woodline Partners' KYMR position worth?

Accepted Answer

As of its Q2 2026 13F, Woodline Partners' KYMR position is worth $57.4M.

Question 4

Is Woodline Partners buying or selling KYMR?

Accepted Answer

In Q2 2026, Woodline Partners increased its KYMR position by 297,283 shares (+146.0%).

Question 5

When did Woodline Partners first buy KYMR?

Accepted Answer

Woodline Partners already held KYMR in its Q3 2020 13F, the earliest on record, and has listed it in 21 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	500,868	+146.0%	$57.4M	0.2%	$114.67	57
2026-Q1	Unchanged	203,585	0.0%	$17M	0.1%	$83.29	0
2025-Q4	Decreased	203,585	-17.9%	$15.8M	0.1%	$77.81	0
2025-Q3	Decreased	248,000	-50.2%	$14M	0.1%	$56.60	0
2025-Q2	Decreased	498,111	-5.2%	$21.7M	0.1%	$43.64	0
2025-Q1	Decreased	525,245	-2.3%	$14.4M	0.1%	$27.37	0
2024-Q4	Increased	537,428	+2.4%	$21.6M	0.1%	$40.23	35
2024-Q3	Increased	525,094	+1.4%	$24.9M	0.2%	$47.33	35